TROG 96.07 - Merkel Cell - Skin - TROG Cancer Research

Read Roland's story about participating in a prostate cancer trial

Trial offers promise for new kidney cancer treatment option

TROG Members: Register now for our Grant Workshop on 29 July 2026

Catch up with our 2025 highlights in our Annual Research Report .

By w.paterson
15 August, 2021
0 Comments

A Phase II Study of Synchronous Carboplatin/Etoposide And Radiation In Merkel Cell Carcinoma Of The Skin

Primary Sponsor

Trans-Tasman Radiation Oncology Group (TROG)

Related Post

ISRS conference

16 June, 2026

TROG members share cutting-edge research at ISRS Congress

LATEST NEWS: 16 June 2026 TROG members highlighted cutting-edge

World Radiotherapy Awareness Day promotion at ESTRO26

10 June, 2026

Global cancer community prepares to unite for 2026 World Radiotherapy Awareness Day

LATEST NEWS: 10 June 2026 The global radiation therapy